UBC PiMS Research Group

Pharmacoepidemiology in Multiple Sclerosis Research Group

Improving MS Drug Safety With Genetics

PIMS team member Kaarina Kowalec recently had a blog post published on MSFHR.org.

Prevalence and Characteristics of Aggressive Type of MS Identified

Suresh Menon's study published in Journal of Neurology, Neurosurgery, and Psychiatry

Ellen Lu published her findings in Neurology

"Birth hospitalization in mothers with multiple sclerosis and their newborns."

What are the causes of death in MS?

Elaine Kingwell's ECTRIMS presentation is discussed on MSology.ca
❙ ❙ « 1 / 4 »
YouTube Preview Image
To improve the outcome of people affected with multiple sclerosis (MS) by furthering knowledge into disease progression and factors that modify or predict progression; the long-term goal being improved prognosis and an individualized approach to the treatment of chronic disease.
Our mission is to foster excellence in multi-disciplinary clinical, therapeutic and epidemiological research to advance knowledge and improve the well-being of those affected by multiple sclerosis.
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada
Tel: 604.822.7121
Email: info.pimsgroup@gmail.com

Welcome to the new UBC PiMS Group Website

Our Research Group is physically located within the University of British Columbia’s hospital. We are also part of the Brain Research Centre, Faculty and Department of Medicine and Division of Neurology. If that wasn’t enough, we are also affiliated with the Vancouver Coastal Health Research Institute.

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada
Email:

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia